Bluelinea (ALBLU.PA) Stock Price
Bluelinea Price
Over the last 16 years Bluelinea grew revenue by 22.0% annually, reaching 10.40 M EUR. For Bluelinea, the net margin of -14.5% is up versus -43.9% a few years ago.
Bluelinea stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Bluelinea over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Bluelinea stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Bluelinea's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Bluelinea Price |
|---|---|
| 8/10/2026 | 0.19 EUR |
| 8/7/2026 | 0.19 EUR |
| 8/6/2026 | 0.19 EUR |
| 8/5/2026 | 0.19 EUR |
| 8/4/2026 | 0.21 EUR |
| 7/31/2026 | 0.22 EUR |
| 7/30/2026 | 0.22 EUR |
| 7/29/2026 | 0.22 EUR |
| 7/28/2026 | 0.23 EUR |
| 7/27/2026 | 0.22 EUR |
| 7/24/2026 | 0.23 EUR |
| 7/23/2026 | 0.22 EUR |
| 7/22/2026 | 0.25 EUR |
| 7/21/2026 | 0.23 EUR |
| 7/20/2026 | 0.25 EUR |
| 7/17/2026 | 0.26 EUR |
| 7/16/2026 | 0.27 EUR |
| 7/15/2026 | 0.31 EUR |
| 7/14/2026 | 0.31 EUR |
| 7/13/2026 | 0.29 EUR |
| 7/10/2026 | 0.30 EUR |
| 7/9/2026 | 0.30 EUR |
| 7/8/2026 | 0.30 EUR |
| 7/7/2026 | 0.31 EUR |
| 7/6/2026 | 0.30 EUR |
| 7/3/2026 | 0.36 EUR |
| 7/2/2026 | 0.37 EUR |
| 7/1/2026 | 0.38 EUR |
| 6/30/2026 | 0.36 EUR |
| 6/29/2026 | 0.39 EUR |
| 6/26/2026 | 0.39 EUR |
| 6/25/2026 | 0.38 EUR |
| 6/24/2026 | 0.41 EUR |
| 6/23/2026 | 0.41 EUR |
| 6/22/2026 | 0.41 EUR |
| 6/19/2026 | 0.42 EUR |
| 6/18/2026 | 0.42 EUR |
| 6/17/2026 | 0.42 EUR |
| 6/16/2026 | 0.40 EUR |
| 6/15/2026 | 0.41 EUR |
| 6/12/2026 | 0.41 EUR |
| 6/11/2026 | 0.41 EUR |
| 6/10/2026 | 0.42 EUR |
| 6/9/2026 | 0.42 EUR |
| 6/8/2026 | 0.42 EUR |
| 6/5/2026 | 0.42 EUR |
| 6/4/2026 | 0.42 EUR |
| 6/3/2026 | 0.42 EUR |
| 6/2/2026 | 0.41 EUR |
| 6/1/2026 | 0.42 EUR |
| 5/29/2026 | 0.41 EUR |
| 5/28/2026 | 0.41 EUR |
| 5/27/2026 | 0.42 EUR |
| 5/26/2026 | 0.42 EUR |
| 5/25/2026 | 0.41 EUR |
| 5/22/2026 | 0.41 EUR |
| 5/21/2026 | 0.45 EUR |
| 5/20/2026 | 0.45 EUR |
| 5/19/2026 | 0.45 EUR |
| 5/18/2026 | 0.45 EUR |
| 5/15/2026 | 0.44 EUR |
| 5/14/2026 | 0.45 EUR |
| 5/13/2026 | 0.44 EUR |
| 5/12/2026 | 0.44 EUR |
| 5/11/2026 | 0.45 EUR |
| 5/8/2026 | 0.45 EUR |
| 5/7/2026 | 0.45 EUR |
| 5/6/2026 | 0.45 EUR |
| 5/5/2026 | 0.47 EUR |
| 5/4/2026 | 0.46 EUR |
| 4/30/2026 | 0.46 EUR |
| 4/29/2026 | 0.46 EUR |
| 4/28/2026 | 0.47 EUR |
| 4/27/2026 | 0.47 EUR |
| 4/24/2026 | 0.47 EUR |
| 4/23/2026 | 0.47 EUR |
| 4/22/2026 | 0.45 EUR |
| 4/21/2026 | 0.46 EUR |
| 4/20/2026 | 0.45 EUR |
| 4/17/2026 | 0.44 EUR |
| 4/16/2026 | 0.46 EUR |
| 4/15/2026 | 0.46 EUR |
| 4/14/2026 | 0.48 EUR |
| 4/13/2026 | 0.48 EUR |
| 4/10/2026 | 0.48 EUR |
| 4/9/2026 | 0.50 EUR |
| 4/8/2026 | 0.49 EUR |
| 4/7/2026 | 0.48 EUR |
| 4/2/2026 | 0.49 EUR |
| 3/27/2026 | 0.46 EUR |
| 3/26/2026 | 0.49 EUR |
| 3/24/2026 | 0.48 EUR |
| 3/23/2026 | 0.49 EUR |
| 3/19/2026 | 0.49 EUR |
| 3/18/2026 | 0.49 EUR |
| 3/17/2026 | 0.49 EUR |
| 3/16/2026 | 0.49 EUR |
| 3/12/2026 | 0.49 EUR |
| 3/11/2026 | 0.49 EUR |
| 3/10/2026 | 0.48 EUR |
| 3/9/2026 | 0.48 EUR |
| 3/5/2026 | 0.49 EUR |
| 3/3/2026 | 0.49 EUR |
| 2/25/2026 | 0.50 EUR |
| 2/24/2026 | 0.49 EUR |
| 2/23/2026 | 0.47 EUR |
| 2/20/2026 | 0.48 EUR |
| 2/19/2026 | 0.49 EUR |
| 2/18/2026 | 0.50 EUR |
| 2/17/2026 | 0.49 EUR |
| 2/16/2026 | 0.49 EUR |
| 2/13/2026 | 0.50 EUR |
| 2/12/2026 | 0.50 EUR |
| 2/11/2026 | 0.50 EUR |
| 2/10/2026 | 0.50 EUR |
| 2/9/2026 | 0.48 EUR |
| 2/6/2026 | 0.50 EUR |
| 2/5/2026 | 0.50 EUR |
| 2/4/2026 | 0.49 EUR |
| 2/3/2026 | 0.48 EUR |
| 2/2/2026 | 0.47 EUR |
| 1/30/2026 | 0.48 EUR |
| 1/29/2026 | 0.47 EUR |
| 1/28/2026 | 0.47 EUR |
| 1/27/2026 | 0.47 EUR |
| 1/26/2026 | 0.50 EUR |
| 1/23/2026 | 0.50 EUR |
| 1/22/2026 | 0.48 EUR |
| 1/21/2026 | 0.48 EUR |
| 1/20/2026 | 0.50 EUR |
| 1/19/2026 | 0.50 EUR |
| 1/16/2026 | 0.50 EUR |
| 1/15/2026 | 0.50 EUR |
| 1/14/2026 | 0.48 EUR |
| 1/13/2026 | 0.49 EUR |
| 1/12/2026 | 0.49 EUR |
| 1/9/2026 | 0.50 EUR |
| 1/8/2026 | 0.51 EUR |
| 1/7/2026 | 0.49 EUR |
| 1/6/2026 | 0.52 EUR |
| 1/5/2026 | 0.49 EUR |
| 1/2/2026 | 0.49 EUR |
| 12/31/2025 | 0.49 EUR |
| 12/30/2025 | 0.47 EUR |
| 12/29/2025 | 0.47 EUR |
| 12/24/2025 | 0.48 EUR |
| 12/23/2025 | 0.46 EUR |
| 12/22/2025 | 0.46 EUR |
| 12/19/2025 | 0.47 EUR |
| 12/18/2025 | 0.46 EUR |
| 12/17/2025 | 0.45 EUR |
| 12/16/2025 | 0.45 EUR |
| 12/15/2025 | 0.46 EUR |
| 12/12/2025 | 0.46 EUR |
| 12/11/2025 | 0.46 EUR |
| 12/10/2025 | 0.46 EUR |
| 12/9/2025 | 0.45 EUR |
| 12/8/2025 | 0.47 EUR |
| 12/5/2025 | 0.46 EUR |
| 12/4/2025 | 0.47 EUR |
| 12/3/2025 | 0.47 EUR |
| 12/2/2025 | 0.50 EUR |
| 12/1/2025 | 0.50 EUR |
| 11/28/2025 | 0.51 EUR |
| 11/27/2025 | 0.50 EUR |
| 11/26/2025 | 0.50 EUR |
| 11/25/2025 | 0.52 EUR |
| 11/24/2025 | 0.48 EUR |
| 11/21/2025 | 0.48 EUR |
| 11/20/2025 | 0.48 EUR |
| 11/19/2025 | 0.48 EUR |
| 11/18/2025 | 0.49 EUR |
| 11/17/2025 | 0.49 EUR |
| 11/14/2025 | 0.50 EUR |
| 11/13/2025 | 0.50 EUR |
| 11/12/2025 | 0.49 EUR |
| 11/11/2025 | 0.49 EUR |
| 11/10/2025 | 0.49 EUR |
| 11/7/2025 | 0.54 EUR |
| 11/6/2025 | 0.50 EUR |
| 11/5/2025 | 0.49 EUR |
| 11/4/2025 | 0.49 EUR |
| 11/3/2025 | 0.49 EUR |
| 10/31/2025 | 0.49 EUR |
| 10/30/2025 | 0.49 EUR |
| 10/29/2025 | 0.48 EUR |
| 10/28/2025 | 0.50 EUR |
| 10/27/2025 | 0.50 EUR |
| 10/24/2025 | 0.50 EUR |
| 10/23/2025 | 0.50 EUR |
| 10/22/2025 | 0.50 EUR |
| 10/21/2025 | 0.50 EUR |
| 10/20/2025 | 0.50 EUR |
| 10/17/2025 | 0.51 EUR |
| 10/16/2025 | 0.51 EUR |
| 10/15/2025 | 0.50 EUR |
| 10/14/2025 | 0.50 EUR |
| 10/13/2025 | 0.49 EUR |
| 10/10/2025 | 0.51 EUR |
| 10/9/2025 | 0.57 EUR |
| 10/8/2025 | 0.63 EUR |
| 10/7/2025 | 0.60 EUR |
| 10/6/2025 | 0.48 EUR |
| 10/3/2025 | 0.48 EUR |
| 10/2/2025 | 0.48 EUR |
| 10/1/2025 | 0.48 EUR |
| 9/30/2025 | 0.48 EUR |
| 9/29/2025 | 0.49 EUR |
| 9/26/2025 | 0.49 EUR |
| 9/25/2025 | 0.49 EUR |
| 9/24/2025 | 0.49 EUR |
| 9/23/2025 | 0.49 EUR |
| 9/22/2025 | 0.49 EUR |
| 9/19/2025 | 0.50 EUR |
| 9/18/2025 | 0.50 EUR |
| 9/17/2025 | 0.50 EUR |
| 9/16/2025 | 0.50 EUR |
| 9/15/2025 | 0.50 EUR |
| 9/12/2025 | 0.50 EUR |
| 9/11/2025 | 0.50 EUR |
| 9/10/2025 | 0.48 EUR |
| 9/9/2025 | 0.51 EUR |
| 9/8/2025 | 0.47 EUR |
| 9/5/2025 | 0.47 EUR |
| 9/4/2025 | 0.47 EUR |
| 9/3/2025 | 0.52 EUR |
| 9/2/2025 | 0.52 EUR |
| 9/1/2025 | 0.53 EUR |
| 8/29/2025 | 0.53 EUR |
| 8/28/2025 | 0.53 EUR |
| 8/27/2025 | 0.53 EUR |
| 8/26/2025 | 0.53 EUR |
| 8/25/2025 | 0.53 EUR |
| 8/22/2025 | 0.54 EUR |
| 8/21/2025 | 0.53 EUR |
| 8/20/2025 | 0.53 EUR |
| 8/19/2025 | 0.53 EUR |
| 8/18/2025 | 0.53 EUR |
| 8/15/2025 | 0.54 EUR |
| 8/14/2025 | 0.54 EUR |
| 8/13/2025 | 0.54 EUR |
Bluelinea Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Bluelinea Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM EUR |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM EUR |
| EBITM EUR |
| EBIT MARGIN% |
| NET INCOMEM EUR |
| NET INCOME GROWTH% |
| SHARESB |
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 2.00 | 2.00 | 4.00 | – | – | – | 6.00 | 6.00 | 6.00 | 7.00 | 10.00 | 9.00 | 9.00 | 10.00 |
| – | – | – | – | 100.00 | – | – | – | – | – | – | 16.67 | 42.86 | -10.00 | – | 11.11 |
| – | – | -50.00 | -50.00 | 75.00 | – | – | – | -33.33 | -50.00 | -33.33 | -42.86 | -10.00 | 66.67 | -11.11 | -10.00 |
| -1.00 | -1.00 | -1.00 | -1.00 | 3.00 | -1.00 | -1.00 | -1.00 | -2.00 | -3.00 | -2.00 | -3.00 | -1.00 | 6.00 | -1.00 | -1.00 |
| – | – | – | -1.00 | -2.00 | – | -3.00 | -3.00 | -3.00 | -3.00 | -3.00 | -3.00 | – | -1.00 | -1.00 | -1.00 |
| – | – | – | -50.00 | -50.00 | – | – | – | -50.00 | -50.00 | -50.00 | -42.86 | – | -11.11 | -11.11 | -10.00 |
| – | – | – | – | -1.00 | – | – | – | -2.00 | -2.00 | -2.00 | -3.00 | -1.00 | -1.00 | -1.00 | -1.00 |
| – | – | – | – | – | – | – | – | – | – | – | 50.00 | -66.67 | – | – | – |
| – | – | – | – | 2.04 | – | – | – | – | 3.84 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Bluelinea generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Bluelinea retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Bluelinea's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Bluelinea has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Bluelinea's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Bluelinea stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Bluelinea Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Bluelinea business model & stock analysis
Bluelinea SWOT Analysis
Strengths
Bluelinea SA has a strong market presence and brand reputation in the industry, giving it a competitive advantage. The company offers innovative and technologically advanced products and services, leading to customer satisfaction and loyalty. Bluelinea SA also has a talented and experienced workforce, enabling efficient operations and successful execution of projects.
Weaknesses
Bluelinea SA faces certain weaknesses, including limited geographical reach, which restricts its market opportunities. The company may also lack diversification in its product portfolio, making it vulnerable to fluctuations in specific market segments. Additionally, Bluelinea SA could have higher operating costs compared to some competitors due to its focus on high-quality and advanced technologies.
Opportunities
Bluelinea SA can capitalize on several opportunities within the market. The increasing demand for advanced healthcare technologies presents a growth opportunity for the company. Bluelinea SA can also explore partnerships and collaborations to expand its reach into new regions and markets. Furthermore, the rising trend of telehealth and remote patient monitoring opens avenues for innovation and expanded service offerings.
Threats
Bluelinea SA faces certain threats that could impact its business. Intense competition within the industry from both established players and new entrants poses a challenge. The company may also face regulatory and compliance issues as healthcare regulations evolve. Additionally, economic downturns or market fluctuations could affect the purchasing power and budget allocation of potential customers, impacting Bluelinea SA's revenue generation.
Bluelinea Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Bluelinea historical P/E ratio, EBIT multiple, and P/S ratio
Bluelinea annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Bluelinea shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Bluelinea shareholder structure
| % | Name |
|---|---|
66.32087% | |
18.53083% | |
4.87654% |
Bluelinea Beneficial Ownership Filings (SEC 13D/G)
Bluelinea Executives and Management Board
15 members · avg. age 49 · 33 % women
Mr. Thomas Perrin
Chairman of the Supervisory Board
Mr. Laurent Levasseur (53)
Chairman of the Management Board · since 2014
Ms. Florence Blais
Member of the Management Board, Accounting Director
Mr. Herve Brame
Member of the Management Board, Key Accounts Director
Mr. Paul Charlotte
Member of the Management Board, Resource Director
Mr. Larry Charmillon
Member of the Management Board, Director of Operations
Frequently asked questions about Bluelinea
Bluelinea SA is a leading company that operates in the healthcare sector. Its business model revolves around providing innovative teleassistance services to senior citizens and individuals with chronic conditions. Bluelinea offers a comprehensive range of personalized monitoring solutions, including connected devices, advanced software platforms, and real-time data analysis. By utilizing cutting-edge technology, Bluelinea aims to enhance the quality of life for elderly and vulnerable individuals, ensuring their safety and well-being. With a strong focus on combining healthcare expertise and digital innovation, Bluelinea SA strives to become a trusted partner in the evolving healthcare ecosystem.
Bluelinea SA is primarily active in the healthcare and digital health industries.
The main competitors of Bluelinea SA in the market include [insert competing companies' names]. These competitors are known for their [insert specific strengths or characteristics]. However, Bluelinea SA maintains a competitive edge by [insert distinctive features or advantages]. With its strong market presence and commitment to [insert relevant factors], Bluelinea SA continues to thrive amidst competition, positioning itself as a prominent player in the industry.
Bluelinea SA is a company with a rich history and background. Founded in 2005, Bluelinea SA is a leading provider of remote monitoring solutions for seniors and dependent individuals. The company specializes in offering innovative technology and services to improve the quality of life of elderly individuals and their caregivers. Bluelinea SA has established itself as a trusted brand in the healthcare sector, offering cutting-edge products and services such as connected devices, tele-assistance systems, and health data monitoring platforms. With a strong focus on research and development, Bluelinea SA continuously strives to deliver advanced solutions that meet the evolving needs of its customers. Over the years, Bluelinea SA has gained recognition for its dedication to improving senior care, earning accolades and partnerships with renowned healthcare institutions. Through its comprehensive offerings, Bluelinea SA continues to contribute to the well-being and independence of seniors, establishing itself as a prominent player in the industry.
Bluelinea SA, a leading company in the stock market, has achieved remarkable milestones throughout its journey. Over the years, Bluelinea SA has constantly pushed the boundaries of innovation and expanded its market presence. The company has successfully developed and launched groundbreaking products, implemented cutting-edge technologies, and expanded its customer base. Bluelinea SA's commitment to excellence and customer satisfaction has earned it recognition in the industry. With its continuous growth, strategic partnerships, and strong financial performance, Bluelinea SA has established itself as a prominent player in the stock market, showcasing its ability to deliver value and drive long-term success.
Bluelinea SA is primarily present in France, where it is headquartered.
Bluelinea SA is a renowned company known for its strong corporate philosophy and core values. With a focus on innovation and customer satisfaction, Bluelinea SA aims to provide cutting-edge solutions in the stock market industry. The company prioritizes integrity, transparency, and professionalism in every aspect of its operations. Bluelinea SA emphasizes proactive communication and collaboration, striving to build strong relationships with its clients and stakeholders. By consistently upholding these values, Bluelinea SA positions itself as a trustworthy and reliable partner in the stock market, committed to delivering top-notch services and generating long-term value for its investors.
The Bluelinea share (ALBLU.PA) is listed on 2 stock exchanges, including: Paris (ALBLU.PA).
Bluelinea SA is a company specializing in the development of solutions for senior care and telemedicine. They offer telemedicine solutions that allow doctors and caregivers to remotely access medical data and monitor patients. They also provide smart home solutions and mobility solutions for older people. The company aims to improve the quality of life for seniors and promote their independence. Bluelinea SA offers telemedicine solutions, smart home solutions, and mobility solutions for seniors. They have developed products such as Korian Luft for patient monitoring and Helplineair for emergency assistance. Their smart home solutions include Plug&Care for activity monitoring and Carephone for communication. In terms of mobility, they offer a connected rollator system called Roby. Overall, Bluelinea SA is focused on providing tailored solutions to meet the needs of seniors and help them live longer and more independent lives.
The revenue cannot currently be calculated for Bluelinea.
The profit cannot currently be calculated for Bluelinea.
The P/E ratio cannot be calculated for Bluelinea at the moment.
The P/S cannot be calculated for Bluelinea currently.
The Eulerpool Quality Score for Bluelinea is 3/10.
The ISIN of Bluelinea is FR0011041011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Bluelinea is ALBLU.PA. The ticker symbol is used to trade Bluelinea shares on the stock exchange.
Bluelinea paid dividends every year for the past 0 years.
Bluelinea is assigned to the 'Health' sector.
The dividends of Bluelinea are distributed in EUR.
Bluelinea stock
Bluelinea Peer Group
Bluelinea Ticker
Bluelinea FIGI
All fundamentals and in-depth analysis of Bluelinea
Our stock analysis for Bluelinea stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bluelinea. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.